ReviewFrontiers in pharmacology2016

Overcoming Barriers to the Market Access of Biosimilars in the European Union: The Case of Biosimilar Monoclonal Antibodies.

Evelien Moorkens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.